BR112021024375A2 - Cápsulas de softgel de liberação retardada - Google Patents

Cápsulas de softgel de liberação retardada

Info

Publication number
BR112021024375A2
BR112021024375A2 BR112021024375A BR112021024375A BR112021024375A2 BR 112021024375 A2 BR112021024375 A2 BR 112021024375A2 BR 112021024375 A BR112021024375 A BR 112021024375A BR 112021024375 A BR112021024375 A BR 112021024375A BR 112021024375 A2 BR112021024375 A2 BR 112021024375A2
Authority
BR
Brazil
Prior art keywords
softgel capsules
delayed release
delayed
capsules
release softgel
Prior art date
Application number
BR112021024375A
Other languages
English (en)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of BR112021024375A2 publication Critical patent/BR112021024375A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

cápsulas de softgel de liberação retardada pedidos relacionados. a presente invenção refere-se a cápsulas de softgel de liberação retardada compreendendo um material de enchimento e uma composição de invólucro dependente do ph, caracterizada em que a natureza de liberação retardada das cápsulas pode ser alcançada sem um revestimento dependente do ph ou adição de polímeros convencionais dependentes do ph.
BR112021024375A 2019-06-03 2020-06-02 Cápsulas de softgel de liberação retardada BR112021024375A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962856601P 2019-06-03 2019-06-03
PCT/US2020/035666 WO2020247352A1 (en) 2019-06-03 2020-06-02 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
BR112021024375A2 true BR112021024375A2 (pt) 2022-04-19

Family

ID=73652472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024375A BR112021024375A2 (pt) 2019-06-03 2020-06-02 Cápsulas de softgel de liberação retardada

Country Status (14)

Country Link
US (1) US20220354800A1 (pt)
EP (1) EP3976022A4 (pt)
JP (1) JP2022535539A (pt)
KR (1) KR20220024189A (pt)
CN (1) CN114072138A (pt)
AR (1) AR119075A1 (pt)
AU (1) AU2020288165A1 (pt)
BR (1) BR112021024375A2 (pt)
CA (1) CA3142702A1 (pt)
CO (1) CO2021018071A2 (pt)
IL (1) IL288653A (pt)
MX (1) MX2021014922A (pt)
TW (1) TW202110426A (pt)
WO (1) WO2020247352A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022104339A1 (en) * 2020-11-11 2022-05-19 R.P. Scherer Technologies, Llc Delayed release softgel capsules
EP4312941A1 (en) * 2021-04-01 2024-02-07 R.P. Scherer Technologies, LLC Phospholipids as anion chelating agents in pharmaceutical formulations
AR126384A1 (es) * 2021-07-06 2023-10-11 Scherer Technologies Llc R P Cápsula blanda
WO2023158777A1 (en) * 2022-02-18 2023-08-24 R.P. Scherer Technologies, Llc Modified release valproic acid softgel capsule
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224020A1 (en) * 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
CN101292965B (zh) * 2007-04-24 2011-12-07 沈阳皓天万嘉医药科技有限公司 一种类β-胡萝卜素微囊及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
EP2461797A4 (en) * 2009-08-05 2014-04-16 7267207 Canada Ltd Corp PROCESS FOR THE PREPARATION FOR FREE SALE OF A GELATIN OR PEPTINE MEDICAMENT
EP2793867B1 (en) * 2011-12-22 2021-01-20 Baes, Erik Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
EP2941245A1 (en) * 2013-01-05 2015-11-11 Elcelyx Therapeutics, Inc. Delayed-release composition comprising biguanide
CA2950311C (en) * 2014-06-23 2019-05-14 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2960620C (en) * 2014-10-06 2018-06-19 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
CN104644609B (zh) * 2015-01-28 2017-06-16 龙标兵 一种功能性咀嚼型软胶囊皮
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
CN108578381A (zh) * 2018-02-27 2018-09-28 广州彤博士健康科技有限公司 可咀嚼性软胶囊外皮的配方及制备方法

Also Published As

Publication number Publication date
JP2022535539A (ja) 2022-08-09
AU2020288165A1 (en) 2022-01-06
CA3142702A1 (en) 2020-12-10
US20220354800A1 (en) 2022-11-10
EP3976022A1 (en) 2022-04-06
MX2021014922A (es) 2022-03-11
CO2021018071A2 (es) 2022-04-19
KR20220024189A (ko) 2022-03-03
CN114072138A (zh) 2022-02-18
WO2020247352A1 (en) 2020-12-10
AR119075A1 (es) 2021-11-24
TW202110426A (zh) 2021-03-16
EP3976022A4 (en) 2023-06-14
IL288653A (en) 2022-02-01

Similar Documents

Publication Publication Date Title
BR112021024375A2 (pt) Cápsulas de softgel de liberação retardada
BR112017012068A2 (pt) composições fornecendo liberação retardada de ativos
MA43518A (fr) 3-azabicyclo[3.1.0]hexanes substitués servant d'inhibiteurs de cétohexokinase
BR112018004620A2 (pt) moduladores da expressão de kras
BR112017023310A2 (pt) composição e método de fabricação da microcápsula
PH12020500641A1 (en) Enteric softgel capsules
WO2015168635A3 (en) Compositions and methods for modulating complement factor b expression
EP3420004A4 (en) COPOLYMER COMPOSITIONS OF OXYGEN AND CAROTENOIDS DERIVED FROM MICROORGANISMS OR PLANTS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING THE COPOLYMERS, AND USES THEREOF
PH12019501293A1 (en) Nutritional compositions containing butyrate and uses thereof
ZA202005153B (en) Enteric softgel capsules
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração
MX2018005456A (es) Capsulas de liberación prolongada recubiertas con película.
BR112018014247A2 (pt) inibição de reação alérgica usando um inibidor il-33
MX2016015092A (es) Inhibidor de proliferacion de celulas madre cancerosas.
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
BR112014032764A2 (pt) composição farmacêutica contendo fimasartana e hidroclorotiazida
BR112021019224A2 (pt) Polinucleotídeos, composições e métodos para expressão de polipeptídeo
BR112017019400A2 (pt) fertilizante iniciador à base de potássio
WO2017004282A8 (en) Musk compositions and methods of use thereof
BR112017023636A2 (pt) suplemento dietético
BR112018001859A2 (pt) comprimido, e, método para produzir um comprimido.
BR112012020959A2 (pt) composicao de encapsulamento de liberacao rapida
MX2021000774A (es) Composiciones de curcuminoides.
MX2022015160A (es) Capsulas de gelatina blanda de liberacion retardada.
WO2016113754A3 (en) Novel oral dosage forms of dimethyl fumarate